Ultrathin-strut stents - towards zero stent-related events?
作者信息
Bangalore Sripal
机构信息
Division of Cardiology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
出版信息
AsiaIntervention. 2025 Jul 30;11(2):e97-e98. doi: 10.4244/AIJ-E-25-00004. eCollection 2025 Jul.
Abstract
摘要
相似文献
1
Ultrathin-strut stents - towards zero stent-related events?超薄支架——能否实现零支架相关事件？
AsiaIntervention. 2025 Jul 30;11(2):e97-e98. doi: 10.4244/AIJ-E-25-00004. eCollection 2025 Jul.
2
Comparison of Ultrathin- Versus Thin-Strut Stents in Patients With High Bleeding Risk PCI: Results From the COMPARE 60/80 HBR Trial: An Open-Label, Randomized, Controlled Trial.高出血风险 PCI 患者中使用超薄-与薄壁支架的比较：来自 COMPARE 60/80 HBR 试验的结果：一项开放标签、随机、对照试验。
Circ Cardiovasc Interv. 2024 Oct;17(10):e014042. doi: 10.1161/CIRCINTERVENTIONS.123.014042. Epub 2024 Oct 1.
3
Procedural safety and outcome of ultrathin strut stents (<60 μm) in the management of very long coronary artery stenosis (>30 mm) - A retrospective real world study.超薄支架（<60μm）治疗超长冠状动脉狭窄（>30mm）的手术安全性及预后——一项回顾性真实世界研究
Am J Cardiovasc Dis. 2020 Aug 15;10(3):182-188. eCollection 2020.
4
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?超薄支柱药物洗脱支架相对于第二代和第三代药物洗脱支架有优势吗？
J Pers Med. 2023 Apr 28;13(5):753. doi: 10.3390/jpm13050753.
5
Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects.超细支撑与细支撑支架在临床前和临床研究对象中的愈合情况及结果
EuroIntervention. 2024 May 20;20(10):e669-e680. doi: 10.4244/EIJ-D-23-00563.
6
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.新一代超小径药物洗脱支架与上一代较厚支架药物洗脱支架治疗冠状动脉疾病的比较。
Circulation. 2018 Nov 13;138(20):2216-2226. doi: 10.1161/CIRCULATIONAHA.118.034456.
7
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials.合并外周动脉疾病患者使用超薄支撑可生物降解聚合物西罗莫司洗脱支架与薄支撑耐用聚合物佐他莫司洗脱支架进行经皮冠状动脉介入治疗的结果：两项随机试验的事后分析
Cardiovasc Diagn Ther. 2023 Aug 31;13(4):673-685. doi: 10.21037/cdt-22-584. Epub 2023 Jul 24.
8
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.小血管病变患者中应用薄支架、超薄支架或极薄支架药物洗脱支架的临床结局：随机 BIO-RESORT 试验的预设分析。
JAMA Cardiol. 2019 Jul 1;4(7):659-669. doi: 10.1001/jamacardio.2019.1776.
9
Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up.超小径药物洗脱支架与标准支架的比较效果：一项具有延长随访的大规模荟萃分析的见解。
Eur J Med Res. 2024 Jul 27;29(1):388. doi: 10.1186/s40001-024-01949-7.
10
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.载有西罗莫司的超亲水性药物洗脱支架与载有依维莫司的药物洗脱支架治疗行经皮冠状动脉介入治疗患者的比较：TALENT 试验三年最终结果。
EuroIntervention. 2022 Aug 19;18(6):492-502. doi: 10.4244/EIJ-D-21-00766.
本文引用的文献
1
Optical Coherence Tomography Versus Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials.光学相干断层扫描与单纯血管造影术在指导复杂病变经皮冠状动脉介入治疗中的比较：一项随机对照试验的荟萃分析
Circ Cardiovasc Interv. 2025 May;18(5):e015141. doi: 10.1161/CIRCINTERVENTIONS.125.015141. Epub 2025 Mar 30.
2
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial.生物适应器植入物与当代药物洗脱支架在瑞典经皮冠状动脉介入治疗中的比较（INFINITY-SWEDEHEART）：一项基于登记、单盲、非劣效、随机对照试验。
Lancet. 2024 Nov 2;404(10464):1750-1759. doi: 10.1016/S0140-6736(24)02227-X. Epub 2024 Oct 28.
3
Is this the end of the ultrathin-strut hypothesis?超薄支柱假说就此终结了吗？
EuroIntervention. 2024 May 20;20(10):e625-e626. doi: 10.4244/EIJ-E-24-00017.
4
Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention.血管内影像学、功能或血管造影指导的冠状动脉介入治疗比较。
J Am Coll Cardiol. 2023 Dec 5;82(23):2167-2176. doi: 10.1016/j.jacc.2023.09.823. Epub 2023 Oct 23.
5
Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2.TUXEDO-2 印度研究的原理和设计：Ultra-Thin strUt Supraflex Cruz 与 XiencE 在伴有多支血管病变的糖尿病患者中的比较-2.
Am Heart J. 2023 Feb;256:128-138. doi: 10.1016/j.ahj.2022.10.082. Epub 2022 Oct 28.
6
Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis.双重治疗CD34抗体涂层西罗莫司洗脱支架与标准药物洗脱冠状动脉支架的临床结局：一项荟萃分析。
Cardiovasc Revasc Med. 2020 Feb;21(2):213-221. doi: 10.1016/j.carrev.2019.04.016. Epub 2019 Apr 17.
7
The Elusive Late Benefit of Biodegradable Polymer Drug-Eluting Stents.可生物降解聚合物药物洗脱支架难以捉摸的晚期益处
Circulation. 2019 Jan 15;139(3):334-336. doi: 10.1161/CIRCULATIONAHA.118.038378.
8
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.新一代超小径药物洗脱支架与上一代较厚支架药物洗脱支架治疗冠状动脉疾病的比较。
Circulation. 2018 Nov 13;138(20):2216-2226. doi: 10.1161/CIRCULATIONAHA.118.034456.
Zotero 插件